HealthEquity, Inc.HQYNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
9.46%
↓ 76% below average
Average (9y)
39.74%
Historical baseline
Range
High:121.29%
Low:9.46%
CAGR
-18.6%
Structural decline
| Period | Value |
|---|---|
| 2025 | 9.46% |
| 2024 | 13.15% |
| 2023 | 22.88% |
| 2022 | 26.08% |
| 2021 | 60.89% |
| 2020 | 121.29% |
| 2019 | 28.02% |
| 2018 | 22.39% |
| 2017 | 32.93% |
| 2016 | 60.29% |